Statins
Statin Therapy, Genetics and Heart Disease - March 25, 2015
NIH Research Matters: Genetics help predict heart disease risk, statin benefits![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Mega J et al, Lancet, March 2015
Mega J et al, Lancet, March 2015
Statins work for those at highest risk of heart attack - study,
the Guardian, Mar 3
Dosing guideline for simvastatin and SLCO1B1,
Clinical Pharmacogenomics Implementation Consortium 2014 update
Pharmacogenetics and statin treatment: Reality or theory?![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Bousoula E et al. Curr Vasc Pharmacol 2015 Jan 30.
Bousoula E et al. Curr Vasc Pharmacol 2015 Jan 30.
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Kim Kyungpil et al. Genome Biol. 2014 (9) 460
Kim Kyungpil et al. Genome Biol. 2014 (9) 460
No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Leusink Maarten et al. Pharmacogenomics 2014 Aug (11) 1471-7
Leusink Maarten et al. Pharmacogenomics 2014 Aug (11) 1471-7
Pharmacogenetics of statin-induced myopathy: A focused review of the clinical translation of pharmacokinetic genetic variants.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Talameh Jasmine A et al. J Pharmacogenomics Pharmacoproteomics 2014 Apr 23. (2)
Talameh Jasmine A et al. J Pharmacogenomics Pharmacoproteomics 2014 Apr 23. (2)
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Ramsey L B et al. Clin. Pharmacol. Ther. 2014 Oct (4) 423-8
Ramsey L B et al. Clin. Pharmacol. Ther. 2014 Oct (4) 423-8
Pharmacogenomics, lipid disorders, and treatment options.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Gryn S E et al. Clin. Pharmacol. Ther. 2014 Jul (1) 36-47
Gryn S E et al. Clin. Pharmacol. Ther. 2014 Jul (1) 36-47
Cardiovascular pharmacogenomics: expectations and practical benefits.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Turner R M et al. Clin. Pharmacol. Ther. 2014 Mar (3) 281-93
Turner R M et al. Clin. Pharmacol. Ther. 2014 Mar (3) 281-93
Genetics and personalized medicine--a role in statin therapy?![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Patel Jaideep et al. Curr Atheroscler Rep 2014 Jan (1) 384
Patel Jaideep et al. Curr Atheroscler Rep 2014 Jan (1) 384
Statin myotoxicity: a review of genetic susceptibility factors.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Needham M et al. Neuromuscul. Disord. 2014 Jan (1) 4-15
Needham M et al. Neuromuscul. Disord. 2014 Jan (1) 4-15
Genetic testing: Genetic risk and statin preventative therapy.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Bahcall OG et al. Nat. Rev. Genet. 2015 Apr 16(4) 194
Bahcall OG et al. Nat. Rev. Genet. 2015 Apr 16(4) 194
No hay comentarios:
Publicar un comentario